ONXOL Side Effects

6146578-1 | Hyponatraemia
on Apr 02, 2009 Male patient from UNITED STATES , weighting 196.2 lb, was diagnosed with non-small cell lung cancer and was treated with Onxol (View Usage). Patient experienced the following unwanted or unexpected effects: hyponatraemia. Onxol dosage: Every 3 Weeks. During the same period patient was treated with CARBOPLATIN (Every 3 Weeks) (View Carboplatin Review and Carboplatin Label ), CP 751,871 (Every 3 Weeks) (View Cp-751,871 Review and Cp-751,871 Label ). Patient was hospitalized.

6146575-6 | Anaemia, Dehydration, Hypokalaemia, Renal Failure Acute, Thrombocytopenia
Patient was taking Onxol (View Usage). Patient had the following side effects: anaemia, dehydration, hypokalaemia, renal failure acute, thrombocytopenia on Apr 02, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 134.5 lb, was diagnosed with breast cancer metastatic and. Onxol dosage: Every Week X3. During the same period patient was treated with SUNITINIB MALATE (SU011248) (View Sunitinib Malate (su011248) Review and Sunitinib Malate (su011248) Label ). Patient was hospitalized.

6139905-2 | Cholecystitis
Adverse event was reported on Mar 23, 2009 by a Female patient taking Onxol (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , weighting 172.0 lb, After Onxol was administered, patient had the following side effects: cholecystitis. During the same period patient was treated with SUNITINIB MALATE (View Sunitinib Malate Review and Sunitinib Malate Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), PROCHLORPERAZINE EDISYLATE (View Prochlorperazine Edisylate Review and Prochlorperazine Edisylate Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), FENTANYL 25 (View Fentanyl-25 Review and Fentanyl-25 Label ), DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ).

6059671-9 | Dehydration, Nausea, Renal Failure Acute, Syncope
on Jan 22, 2009 Male patient from UNITED STATES , 73 years of age, weighting 146.5 lb, was diagnosed with non-small cell lung cancer and was treated with Onxol (View Usage). Patient experienced the following unwanted or unexpected effects: dehydration, nausea (What is nausea?), renal failure acute, syncope. Onxol dosage: On Day 1 Of 21 Day Cycle. During the same period patient was treated with CARBOPLATIN (Auc 6 Calvert F, On Day 1 Of 21 Day Cycle) (View Carboplatin Review and Carboplatin Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), INEGY (View Inegy Review and Inegy Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), ONDANSETRON (View Ondansetron Review and Ondansetron Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.


6042709-2 | Macular Oedema
on Jan 12, 2009 Female patient from UNITED STATES , 56 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Onxol (View Usage). Patient had the following side effects: macular oedema. Onxol dosage: 400 Mg Every Three Weeks.

5960873-8 | Systemic Lupus Erythematosus
Patient was taking Onxol (View Usage). After Onxol was administered, patient had the following side effects: systemic lupus erythematosus on Nov 17, 2008 from UNITED STATES Additional patient health information: Female patient , 49 years of age, was diagnosed with ovarian cancer and. Onxol dosage: . During the same period patient was treated with CARBOPLATIN (View Carboplatin Review and Carboplatin Label ).

5856321-9 | Sickle Cell Anaemia With Crisis
Adverse event was reported on Aug 15, 2008 by a Female patient taking Onxol (View Usage) (Dosage: 80 Mg/m2 Weekly) was diagnosed with breast cancer (What is breast cancer?), pneumonia (What is pneumonia?) and. Location: UNITED STATES , 55 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: sickle cell anaemia with crisis. During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5854205-3 | Sickle Cell Anaemia With Crisis
on Aug 15, 2008 Female patient from UNITED STATES , 55 years of age, weighting 189.6 lb, was diagnosed with breast cancer (What is breast cancer?), pneumonia (What is pneumonia?) and was treated with Onxol (View Usage). Patient had the following side effects: sickle cell anaemia with crisis. Onxol dosage: 80 Mg/m2 Weekly. During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ANTIBIOTICS (View Antibiotics Review and Antibiotics Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ). Patient was hospitalized.

5827406-8 | Sickle Cell Anaemia With Crisis
on Jul 21, 2008 Female patient from UNITED STATES , 55 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Onxol (View Usage). After Onxol was administered, patient had the following side effects: sickle cell anaemia with crisis. Onxol dosage: . Patient was hospitalized.

5711380-9 | Osteoarthritis
Patient was taking Onxol (View Usage). Patient experienced the following unwanted or unexpected effects: osteoarthritis (What is osteoarthritis?) on Apr 16, 2008 from UNITED STATES Additional patient health information: Female patient , 59 years of age, was diagnosed with papillary serous endometrial carcinoma and. Onxol dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).